Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat.

× No keyword cloud information.

15 in total

Review 1. Plasma level monitoring of antipsychotic drugs.

Authors: T B Cooper
Journal: Clin Pharmacokinet Date: 1978 Jan-Feb Impact factor: 6.447

2. Pharmacokinetics of intravenous anaesthetics: implications for clinical use.

Authors: M M Ghoneim; K Korttila
Journal: Clin Pharmacokinet Date: 1977 Sep-Oct Impact factor: 6.447

3. Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain.

Authors: R Ohman; M Larsson; I M Nilsson; J Engel; A Carlsson
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-09 Impact factor: 3.000

Review 4. Pharmacokinetics of haloperidol: an update.

Authors: S Kudo; T Ishizaki
Journal: Clin Pharmacokinet Date: 1999-12 Impact factor: 6.447

5. Population pharmacokinetics of haloperidol using routine clinical pharmacokinetic data in Japanese patients.

Authors: Eiji Yukawa; Tsuyoshi Hokazono; Miho Yukawa; Ritsuko Ichimaru; Takako Maki; Kanemitsu Matsunaga; Shigehiro Ohdo; Motoaki Anai; Shun Higuchi; Yoshinobu Goto
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

6. Plasma level profile of haloperidol in man following intramuscular administration.

Authors: W A Cressman; J R Bianchine; V B Slotnick; P C Johnson; J Plostnieks
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

7. Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol.

Authors: J Fang; G B Baker; P H Silverstone; R T Coutts
Journal: Cell Mol Neurobiol Date: 1997-04 Impact factor: 5.046

8. Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

Authors: J Fang; P H Yu; J W Gorrod; A A Boulton
Journal: Psychopharmacology (Berl) Date: 1995-03 Impact factor: 4.530

9. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.

Authors: Jo Ann V Antenor-Dorsey; Richard Laforest; Stephen M Moerlein; Tom O Videen; Joel S Perlmutter
Journal: Eur J Nucl Med Mol Imaging Date: 2007-12-11 Impact factor: 9.236

10. Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone.

Authors: J Chivers; P Jenner; C D Marsden
Journal: Br J Pharmacol Date: 1987-03 Impact factor: 8.739